April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Compared with N-acetylcysteine (NAC), N-Acetylcysteine Amide (NACA) Provides Increased Protection of Cone Function in a Model of Retinitis Pigmentosa
Author Affiliations & Notes
  • Aling Dong
    Johns Hopkins University Wilmer Eye Institute, Baltimore, MD
  • Rebecca Stevens
    Johns Hopkins University Wilmer Eye Institute, Baltimore, MD
  • Sean Hackett
    Johns Hopkins University Wilmer Eye Institute, Baltimore, MD
  • Peter A Campochiaro
    Johns Hopkins University Wilmer Eye Institute, Baltimore, MD
  • Footnotes
    Commercial Relationships Aling Dong, None; Rebecca Stevens, None; Sean Hackett, None; Peter Campochiaro, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1736. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Aling Dong, Rebecca Stevens, Sean Hackett, Peter A Campochiaro; Compared with N-acetylcysteine (NAC), N-Acetylcysteine Amide (NACA) Provides Increased Protection of Cone Function in a Model of Retinitis Pigmentosa. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1736.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Retinitis pigmentosa (RP) is a major cause of blindness due to a large variety of mutations that lead to the death of rod photoreceptors. After rods die, cones gradually die from progressive oxidative damage. We previously found that N-acetylcysteine (NAC), a well-known thiol antioxidant, reduces cone cell death and preserves cone function in models of RP. N-acetylcysteine amide (NACA) is a prodrug for NAC with increased bioavailability. In this study, we compared NAC and NACA in a model of RP.

Methods: Starting at postnatal day (P) 14, rd10+/+ mice were given normal drinking water (n=6) or water containing 7mg/ml NACA or 20mg/ml NAC (n=8 for each group). Scotopic and photopic electroretinograms (ERGs) were recorded at P35 and P50. Cone density was measured at P50 in four 230 mmx 230 mm (512x512 pixels) areas located 0.5mm superior, temporal, inferior, and nasal to the center of the optic nerve in retinal flat mounts stained with fluorescein-labeled peanut agglutinin (PNA).

Results: At P35, mean peak scotopic ERG b-wave amplitude was similar in rd10+/+ mice treated with 7mg/ml NACA or 20mg/ml NAC, and were significantly greater (about 2-fold) than those in controls. Mean peak photopic b-wave amplitude was 41% higher (p=0.024) in NACA-treated mice than NAC-treated mice and both were more than 3-fold higher than that in controls. At P50, mean peak scotopic ERG b-wave amplitude was more than 5-fold higher in NAC- or NACA-treated mice than in controls with mean b-wave amplitudes significantly greater in NACA-treated mice compared with NAC-treated mice at 10 of 11 stimulus intensities. Mean photopic ERG b-wave amplitude was 50% higher (p=0.001) at all 3 stimulus intensities in NACA-treated versus NAC-treated mice and more than 4-fold greater than controls. At P50, cone cell density was significantly greater in 3 of 4 quadrants in NACA-treated mice compared to NAC-treated mice.

Conclusions: Even with a substantially lower oral dose, NACA showed significantly greater preservation of cone cell function and cone survival compared with NAC in rd10+/+ mice.

Keywords: 702 retinitis • 424 antioxidants • 449 cell survival  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×